Growth Metrics

Inogen (INGN) Interest Expenses (2013 - 2022)

Inogen (INGN) reported Interest Expenses of $12000.0 for Q3 2022, down 97.42% year-over-year from $466000.0 in Q3 2021, and down 97.42% on a QoQ basis from $466000.0 in Q3 2021.

Inogen (INGN) has 6 years of Interest Expenses data on file, last reported at $12000.0 in Q3 2022.

  • Quarterly Interest Expenses fell 97.42% year-over-year to $12000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $12000.0 (down 97.42% YoY) and the FY2016 annual result came in at $6000.0, down 72.73% from the prior year.
  • Interest Expenses declined to $12000.0 in Q3 2022 per INGN's latest filing, from $466000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $466000.0 in Q3 2021 and bottomed at $12000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 174.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 148.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 96.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.10 Mn
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 12,000.00
Sep 30, 2022 12,000.00
Sep 30, 2021 466,000.00
Sep 30, 2021 466,000.00
Sep 30, 2016 1,000.00
Sep 30, 2016 1,000.00
Jun 30, 2016 2,000.00
Jun 30, 2016 2,000.00
Mar 31, 2016 3,000.00
Mar 31, 2016 3,000.00
Dec 31, 2015 4,000.00
Dec 31, 2015 4,000.00
Sep 30, 2015 5,000.00
Sep 30, 2015 5,000.00
Jun 30, 2015 6,000.00
Jun 30, 2015 6,000.00
Mar 31, 2015 7,000.00
Mar 31, 2015 7,000.00
Dec 31, 2014 9,000.00
Dec 31, 2014 9,000.00
Sep 30, 2014 104,000.00
Sep 30, 2014 104,000.00
Jun 30, 2014 203,000.00
Jun 30, 2014 203,000.00
Mar 31, 2014 133,000.00
Mar 31, 2014 133,000.00
Dec 31, 2013 250,000.00
Dec 31, 2013 250,000.00
Sep 30, 2013 113,000.00
Sep 30, 2013 113,000.00
Jun 30, 2013 95,000.00
Jun 30, 2013 95,000.00
Mar 31, 2013 104,000.00
Mar 31, 2013 104,000.00